Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999
- PMID: 11446571
Influenza and pneumococcal vaccination levels among persons aged > or = 65 years--United States, 1999
Abstract
Annual influenza epidemics have resulted in an average of >18,000 deaths and 48,000 pneumonia and influenza hospitalizations among older persons in the United States (1). In 1998, an estimated 3400 older persons died from bacteremic pneumococcal pneumonia, a common complication of influenza, or from other forms of invasive pneumococcal disease (2 ). A 2000 national health objective included increasing influenza and pneumococcal vaccination levels to > or = 60% among noninstitutionalized, high-risk persons, including those aged > or = 65 years (3). To assess progress toward this objective, data were analyzed from the 1999 Behavioral Risk Factor Surveillance System (BRFSS) for persons aged > or = 65 years. This report summarizes the results of that analysis, which indicated that prevalence of influenza vaccination during the 1998-99 influenza season exceeded the objective nationally and in 48 of 52 reporting areas; however, influenza vaccination levels may have reached a plateau. Prevalence among older persons who had ever received pneumococcal vaccination exceeded the national objective in only eight states. To reach the 2010 national objective of > or = 90% influenza and pneumococcal vaccination among this population, new strategies and additional resources to implement adult vaccination activities may be needed.
Similar articles
-
Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma--United States, 2003.MMWR Morb Mortal Wkly Rep. 2004 Nov 5;53(43):1007-12. MMWR Morb Mortal Wkly Rep. 2004. PMID: 15525897
-
Influenza and pneumococcal vaccination levels among adults aged > or =65 years--United States, 1997.MMWR Morb Mortal Wkly Rep. 1998 Oct 2;47(38):797-802. MMWR Morb Mortal Wkly Rep. 1998. PMID: 9776166
-
Pneumococcal and influenza vaccination levels among adults aged > or = 65 years--United States, 1993.MMWR Morb Mortal Wkly Rep. 1996 Oct 11;45(40):853-9. MMWR Morb Mortal Wkly Rep. 1996. PMID: 8927004
-
[Pneumococcal vaccination in adults].Ned Tijdschr Geneeskd. 2003 Mar 8;147(10):437-41. Ned Tijdschr Geneeskd. 2003. PMID: 12666513 Review. Dutch.
-
Prevention of respiratory infections in adults. Influenza and pneumococcal vaccines.Arch Intern Med. 1994 Nov 28;154(22):2545-57. Arch Intern Med. 1994. PMID: 7979851 Review.
Cited by
-
The provision of pharmaceutical advice improves patient vaccination status.Pharm Pract (Granada). 2006 Oct;4(4):163-7. doi: 10.4321/s1885-642x2006000400003. Pharm Pract (Granada). 2006. PMID: 25214905 Free PMC article.
-
Occurrence of invasive pneumococcal disease and number of excess cases due to influenza.BMC Infect Dis. 2006 Mar 20;6:58. doi: 10.1186/1471-2334-6-58. BMC Infect Dis. 2006. PMID: 16549029 Free PMC article.
-
Antiviral agents for influenza: a comparison of cost-effectiveness data.Pharmacoeconomics. 2005;23(11):1083-106. doi: 10.2165/00019053-200523110-00003. Pharmacoeconomics. 2005. PMID: 16277546 Review.
-
Age-related defects in CD4 T cell cognate helper function lead to reductions in humoral responses.J Exp Med. 2004 Dec 20;200(12):1613-22. doi: 10.1084/jem.20041395. J Exp Med. 2004. PMID: 15611289 Free PMC article.
-
Tailoring interventions: understanding medical practice culture.J Cross Cult Gerontol. 2004 Jun;19(2):47-76. doi: 10.1023/B:JCCG.0000027845.23006.e8. J Cross Cult Gerontol. 2004. PMID: 15146138
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical